Category

Middle Childhood
  A recent study that has appeared in the journal NeuroImage:Clinical, reports that subjects who had been treated with methylphenidate (Ritalin) before the age of 16, had significantly lower levels of the inhibitory neurotransmitter gamma-Aminobutyric acid (GABA) as adults, compared with subjects who had started methylphenidate therapy after age 23, and subjects who had never taken...
Read More
Over the next month, 55+ million children and adolescents will be returning to their classrooms in public and private schools around the country. Out of this number, 6.4 million students have been diagnosed as having ADHD and most of them take psychostimulants or other drugs to control their symptoms. And while parents scurry around anxiously...
Read More
The following is excerpted from my new book The Myth of the ADHD Child: 101 Ways to Improve Your Child’s Behavior and Attention Span Without Drugs, Labels, or Coercion (Tarcher-Perigee).  It is Strategy #67: Discover and Manage the Four Types of Misbehavior (Ages 4-18).  The excerpt originally appeared on the website of Sarah MacLaughlin, LSW....
Read More
The following strategies are described in my new book:  The Myth of the ADHD Child:  101 Ways to Improve Your Child’s Behavior and Attention Span without Drugs, Labels, or Coercion (Tarcher/Perigee). Let Your Child Fidget Channel Creative Energies into the Arts Emphasize Diversity, Not Disability Enroll Your Child in a Martial Arts Class Make Time...
Read More
I read an online article today from Benzinga, a financial media company that empowers its readers with daily actionable market analysis and commentary.  It reported on a new ADHD drug that the FDA had just approved, called Cotempla XR-OTD, a methylphenidate extended release orally-disintegrating tablet for treating ADHD in kids aged 6-17.  According to BMO...
Read More
1 2 3 7

Article Archives